Fiduciary Family Office LLC Invests $704,000 in Colgate-Palmolive (NYSE:CL)

Fiduciary Family Office LLC bought a new position in shares of Colgate-Palmolive (NYSE:CL) during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm bought 6,780 shares of the company’s stock, valued at approximately $704,000.

Several other hedge funds and other institutional investors have also made changes to their positions in CL. E Fund Management Hong Kong Co. Ltd. purchased a new stake in shares of Colgate-Palmolive in the second quarter valued at approximately $25,000. Continuum Advisory LLC boosted its stake in shares of Colgate-Palmolive by 46.5% in the second quarter. Continuum Advisory LLC now owns 394 shares of the company’s stock valued at $38,000 after buying an additional 125 shares in the last quarter. Reston Wealth Management LLC purchased a new stake in Colgate-Palmolive during the third quarter worth $42,000. Gradient Investments LLC boosted its position in Colgate-Palmolive by 150.4% during the second quarter. Gradient Investments LLC now owns 666 shares of the company’s stock worth $65,000 after purchasing an additional 400 shares in the last quarter. Finally, Financial Connections Group Inc. purchased a new stake in Colgate-Palmolive during the second quarter worth $68,000. Institutional investors and hedge funds own 80.41% of the company’s stock.

Insider Transactions at Colgate-Palmolive

In other news, insider Panagiotis Tsourapas sold 14,794 shares of the company’s stock in a transaction dated Thursday, August 8th. The stock was sold at an average price of $102.94, for a total value of $1,522,894.36. Following the completion of the sale, the insider now owns 5,146 shares of the company’s stock, valued at $529,729.24. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. In related news, Director Martina Hundmejean sold 2,313 shares of the stock in a transaction dated Friday, August 23rd. The stock was sold at an average price of $103.86, for a total value of $240,228.18. Following the completion of the transaction, the director now owns 11,755 shares of the company’s stock, valued at approximately $1,220,874.30. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, insider Panagiotis Tsourapas sold 14,794 shares of the company’s stock in a transaction that occurred on Thursday, August 8th. The shares were sold at an average price of $102.94, for a total value of $1,522,894.36. Following the sale, the insider now owns 5,146 shares in the company, valued at $529,729.24. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 0.37% of the company’s stock.

Analyst Ratings Changes

A number of analysts have commented on CL shares. TD Cowen decreased their target price on Colgate-Palmolive from $115.00 to $110.00 and set a “buy” rating on the stock in a research report on Monday, October 28th. Piper Sandler started coverage on Colgate-Palmolive in a research report on Tuesday, September 24th. They set an “overweight” rating and a $121.00 target price on the stock. JPMorgan Chase & Co. boosted their target price on Colgate-Palmolive from $113.00 to $114.00 and gave the stock an “overweight” rating in a research report on Friday, October 11th. Hsbc Global Res downgraded Colgate-Palmolive from a “strong-buy” rating to a “hold” rating in a research report on Friday, July 26th. Finally, Sanford C. Bernstein boosted their price target on Colgate-Palmolive from $100.00 to $103.00 and gave the stock a “market perform” rating in a report on Tuesday, July 30th. One research analyst has rated the stock with a sell rating, ten have given a hold rating and twelve have given a buy rating to the company’s stock. According to MarketBeat, Colgate-Palmolive currently has a consensus rating of “Hold” and an average target price of $105.11.

Colgate-Palmolive Trading Up 0.5 %

NYSE:CL traded up $0.51 on Tuesday, hitting $94.12. 584,189 shares of the stock were exchanged, compared to its average volume of 4,343,643. The stock has a market cap of $76.90 billion, a PE ratio of 26.82, a PEG ratio of 3.33 and a beta of 0.42. The company has a current ratio of 1.04, a quick ratio of 0.68 and a debt-to-equity ratio of 9.46. The stock has a fifty day moving average of $102.03 and a 200-day moving average of $98.40. Colgate-Palmolive has a fifty-two week low of $74.67 and a fifty-two week high of $109.30.

Colgate-Palmolive Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, November 15th. Stockholders of record on Friday, October 18th will be given a $0.50 dividend. This represents a $2.00 annualized dividend and a dividend yield of 2.12%. The ex-dividend date is Friday, October 18th. Colgate-Palmolive’s payout ratio is 57.31%.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.